WEST PHARMACEUTICAL SERVICES, INC. Write off of Deferred Debt Issuance Cost
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Write off of Deferred Debt Issuance Cost of $4.40 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2012-08-06
- 2012-06-30: Write off of Deferred Debt Issuance Cost 6 month $4.40M.
| Period end | Write off of Deferred Debt Issuance Cost 6 month |
|---|---|
| 2012-06-30 | $4.40M 10-Q · filed 2012-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |